7,428 followers
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer https://t.co/uw3JQekDxU
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer https://t.co/uw3JQekDxU
RT @FDAOncology: FDA Approval Summary: Margetuximab plus chemotherapy for advanced or metastatic HER2-positive breast cancer, via @CCR_AACR…
RT @FDAOncology: FDA Approval Summary: Margetuximab plus chemotherapy for advanced or metastatic HER2-positive breast cancer, via @CCR_AACR…
RT @FDAOncology: FDA Approval Summary: Margetuximab plus chemotherapy for advanced or metastatic HER2-positive breast cancer, via @CCR_AACR…